|
Mar 7
|
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know
|
|
Mar 5
|
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
|
|
Nov 9
|
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
|
|
Nov 7
|
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
|
|
Sep 27
|
Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
|